Clinical Trial

Sports Nutrition Benefits of Weizmannia Coagulans BC99

Completed
View on ClinicalTrials.gov →
Summary
To evaluate the clinical efficacy of Weizmannia coagulans BC99 in young Chinese patients with exercise-induced muscle damage compared with placebo, and to explore its effects on inflammatory responses and intestinal microbiota.
Trial Details
NCT Number NCT07325409
Lead Sponsor Wecare Probiotics Co., Ltd.
Conditions College Students of the School of Physical Education
Enrollment 72 participants
Start Date 2023-11-01
Primary Completion 2024-03-10 (estimated)
Study Completion 2024-03-28 (estimated)
Updated on ClinicalTrials.gov 2026-01-08